208 related articles for article (PubMed ID: 18955645)
1. Levels of sex steroid and cardiovascular disease measures in premenopausal and hormone-treated women at midlife: implications for the "timing hypothesis".
Sowers MR; Randolph J; Jannausch M; Lasley B; Jackson E; McConnell D
Arch Intern Med; 2008 Oct; 168(19):2146-53. PubMed ID: 18955645
[TBL] [Abstract][Full Text] [Related]
2. Interleukins 6 and 8 and abdominal fat depots are distinct correlates of lipid moieties in healthy pre- and postmenopausal women.
Veldhuis JD; Dyer RB; Trushin SA; Bondar OP; Singh RJ; Klee GG
Endocrine; 2016 Dec; 54(3):671-680. PubMed ID: 27444747
[TBL] [Abstract][Full Text] [Related]
3. Sex hormone levels and risk of breast cancer with estrogen plus progestin.
Farhat GN; Parimi N; Chlebowski RT; Manson JE; Anderson G; Huang AJ; Vittinghoff E; Lee JS; Lacroix AZ; Cauley JA; Jackson R; Grady D; Lane DS; Phillips L; Simon MS; Cummings SR
J Natl Cancer Inst; 2013 Oct; 105(19):1496-503. PubMed ID: 24041978
[TBL] [Abstract][Full Text] [Related]
4. Lipids and cardiovascular disease: do the findings and therapy apply equally to men and women?
LaRosa JC
Womens Health Issues; 1992; 2(2):102-11; discussion 111-3. PubMed ID: 1617306
[TBL] [Abstract][Full Text] [Related]
5. The association of elective hormone therapy with changes in lipids among glucose intolerant postmenopausal women in the diabetes prevention program.
Golden SH; Kim C; Barrett-Connor E; Nan B; Kong S; Goldberg R;
Metabolism; 2013 Sep; 62(9):1313-22. PubMed ID: 23660512
[TBL] [Abstract][Full Text] [Related]
6. The effects of compounded bioidentical transdermal hormone therapy on hemostatic, inflammatory, immune factors; cardiovascular biomarkers; quality-of-life measures; and health outcomes in perimenopausal and postmenopausal women.
Stephenson K; Neuenschwander PF; Kurdowska AK
Int J Pharm Compd; 2013; 17(1):74-85. PubMed ID: 23627249
[TBL] [Abstract][Full Text] [Related]
7. Racial differences in body composition and cardiometabolic risk during the menopause transition: a prospective, observational cohort study.
Marlatt KL; Redman LM; Beyl RA; Smith SR; Champagne CM; Yi F; Lovejoy JC
Am J Obstet Gynecol; 2020 Apr; 222(4):365.e1-365.e18. PubMed ID: 31610152
[TBL] [Abstract][Full Text] [Related]
8. Determinants of sex hormone-binding globulin blood concentrations in premenopausal and postmenopausal women with different estrogen status. Virgilio-Menopause-Health Group.
Pasquali R; Vicennati V; Bertazzo D; Casimirri F; Pascal G; Tortelli O; Labate AM
Metabolism; 1997 Jan; 46(1):5-9. PubMed ID: 9005961
[TBL] [Abstract][Full Text] [Related]
9. The relation of endogenous sex steroid hormone concentrations to serum lipid and lipoprotein levels in postmenopausal women.
Cauley JA; Gutai JP; Kuller LH; Powell JG
Am J Epidemiol; 1990 Nov; 132(5):884-94. PubMed ID: 2239903
[TBL] [Abstract][Full Text] [Related]
10. The effects of postmenopausal hormone therapy on serum estrogen, progesterone, and sex hormone-binding globulin levels in healthy postmenopausal women.
Edlefsen KL; Jackson RD; Prentice RL; Janssen I; Rajkovic A; O'Sullivan MJ; Anderson G
Menopause; 2010; 17(3):622-9. PubMed ID: 20215977
[TBL] [Abstract][Full Text] [Related]
11. Oral contraceptive and postmenopausal estrogen effects on lipoprotein triglyceride and cholesterol in an adult female population: relationships to estrogen and progestin potency.
Knopp RH; Walden CE; Wahl PW; Hoover JJ; Warnick GR; Albers JJ; Ogilvie JT; Hazzard WR
J Clin Endocrinol Metab; 1981 Dec; 53(6):1123-32. PubMed ID: 7298796
[TBL] [Abstract][Full Text] [Related]
12. Association of Serum Sex Hormones with Hemostatic Factors in Women On and Off Hormone Therapy: The Multiethnic Study of Atherosclerosis.
Williams MS; Cushman M; Ouyang P; Heckbert SR; Kalyani RR; Vaidya D
J Womens Health (Larchmt); 2016 Feb; 25(2):166-72. PubMed ID: 26700933
[TBL] [Abstract][Full Text] [Related]
13. Association of hormone-replacement therapy with various cardiovascular risk factors in postmenopausal women. The Atherosclerosis Risk in Communities Study Investigators.
Nabulsi AA; Folsom AR; White A; Patsch W; Heiss G; Wu KK; Szklo M
N Engl J Med; 1993 Apr; 328(15):1069-75. PubMed ID: 8384316
[TBL] [Abstract][Full Text] [Related]
14. Sex hormone levels and risk of cardiovascular events in postmenopausal women.
Rexrode KM; Manson JE; Lee IM; Ridker PM; Sluss PM; Cook NR; Buring JE
Circulation; 2003 Oct; 108(14):1688-93. PubMed ID: 12975257
[TBL] [Abstract][Full Text] [Related]
15. Estrogenic effect of yam ingestion in healthy postmenopausal women.
Wu WH; Liu LY; Chung CJ; Jou HJ; Wang TA
J Am Coll Nutr; 2005 Aug; 24(4):235-43. PubMed ID: 16093400
[TBL] [Abstract][Full Text] [Related]
16. Case-control study of endogenous steroid hormones and endometrial cancer.
Potischman N; Hoover RN; Brinton LA; Siiteri P; Dorgan JF; Swanson CA; Berman ML; Mortel R; Twiggs LB; Barrett RJ; Wilbanks GD; Persky V; Lurain JR
J Natl Cancer Inst; 1996 Aug; 88(16):1127-35. PubMed ID: 8757192
[TBL] [Abstract][Full Text] [Related]
17. Small low-density lipoprotein particles in women with natural or surgically induced menopause.
Ikenoue N; Wakatsuki A; Okatani Y
Obstet Gynecol; 1999 Apr; 93(4):566-70. PubMed ID: 10214834
[TBL] [Abstract][Full Text] [Related]
18. A longitudinal study of the perimenopausal transition: altered profiles of steroid and pituitary hormones, SHBG and bone mineral density.
Rannevik G; Jeppsson S; Johnell O; Bjerre B; Laurell-Borulf Y; Svanberg L
Maturitas; 1995 Feb; 21(2):103-13. PubMed ID: 7752947
[TBL] [Abstract][Full Text] [Related]
19. Serum sex hormones in premenopausal women with coronary heart disease.
Mohamad MJ; Karayyem M; Mohammad MA; Al-Alami J; Al-Hader A
Neuro Endocrinol Lett; 2006 Dec; 27(6):758-62. PubMed ID: 17186999
[TBL] [Abstract][Full Text] [Related]
20. Effect of estrogen/progestin potency on lipid/lipoprotein cholesterol.
Wahl P; Walden C; Knopp R; Hoover J; Wallace R; Heiss G; Rifkind B
N Engl J Med; 1983 Apr; 308(15):862-7. PubMed ID: 6572785
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
